Skip to main content
CLBT
NASDAQ Technology

Cellebrite Reports Record Q4 & Full-Year 2025 Results, Strong 2026 Outlook, and Strategic Drone Forensics Acquisition

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
8
Price
$15.9
Mkt Cap
$3.578B
52W Low
$13.1
52W High
$25.87
Market data snapshot near publication time

summarizeSummary

Cellebrite announced record fourth-quarter and full-year 2025 financial results, provided a strong 2026 outlook, and revealed a strategic acquisition to enter the drone forensics market.


check_boxKey Events

  • Record Q4 and Full-Year 2025 Financials

    Cellebrite reported record Q4 2025 revenue of $128.8 million (up 18% year-over-year) and full-year 2025 revenue of $475.7 million (up 19% year-over-year). Total ARR grew 21% to $480.8 million, with organic ARR up 17% to $464.7 million. GAAP net income for Q4 was $21.3 million and $78.3 million for the full year.

  • Strong 2026 Financial Outlook

    The company provided a positive outlook for 2026, projecting full-year ARR between $567 million and $573 million (18%-19% annual growth) and revenue between $565 million and $571 million (19%-20% annual growth). Adjusted EBITDA is expected to be between $149 million and $155 million, maintaining strong margins.

  • Strategic Acquisition of SCG Canada

    Cellebrite announced an agreement to acquire SCG Canada Inc., a leader in portable drone forensics. This acquisition is expected to broaden Cellebrite's digital forensics capabilities, targeting a market where drone data is anticipated to become the second most valuable data source after mobile phones. The deal is expected to close later this quarter.

  • Exceeded Inseyets Conversion Target

    Cellebrite ended 2025 with approximately 55% of its installed digital forensics license base converted to Inseyets, surpassing its original target of 50%, validating its market and technology leadership.


auto_awesomeAnalysis

Cellebrite DI Ltd. delivered robust financial performance for both the fourth quarter and full-year 2025, marked by record revenue and strong Annual Recurring Revenue (ARR) growth. The company's positive momentum is expected to continue into 2026, as indicated by its optimistic financial outlook. A significant strategic development is the planned acquisition of SCG Canada, which will expand Cellebrite's capabilities into the rapidly growing drone forensics market, positioning it for future growth in a critical data source. Additionally, the company exceeded its target for Inseyets license conversions and is increasing investment in AI, signaling strong product adoption and innovation.

At the time of this filing, CLBT was trading at $15.90 on NASDAQ in the Technology sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $13.10 to $25.87. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CLBT - Latest Insights

CLBT
Mar 02, 2026, 8:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
CLBT
Feb 11, 2026, 7:15 AM EST
Filing Type: 6-K
Importance Score:
8